|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted that the trocar balloon, lock collar, valve seal, and converter doors were intact.The obturator was received, while the insufflation syringe was not.For functional testing, a test syringe was used to successfully inflate the balloon.The lock collar moved freely along the cannula and locked securely in place.The valve door opened and closed properly when actuated, and the converter doors functioned and locked as expected.A test insufflation bulb was attached, and air flowed unrestricted through the tubing and cannula.A water bath test showed no air bubbles, indicating no leakage.It was reported that the balloon did not inflate.The reported issue could not be confirmed.The most likely cause could not be established from the information available.The evaluation detected an unreported condition of distorted balloon.The product analysis noted evidence that the device was not used as intended.This issue may occur when positioning the device during its inflation deployment or deflation process, or its tissue planes process, during clinical application.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.A secondary review of the device history records found no potentially contributing factors.The instructions included with this device provide the following guidance: once the extraperitoneal space is adequately dissected, deflate the dissection balloon by removing the endoscope or by removing the inflation bulb from the dissector.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|